Is Neuroone Medical Technologies Corp (NMTC) overvalued? · rev $3.5M
Neuroone Medical Technologies Corp (NMTC) is a medical devices company listed on US.
This page asks whether Neuroone Medical Technologies Corp (NMTC) looks expensive on cached numbers — not a short thesis.
Latest reported NMTC revenue for 2024-09-30 was $3.5M. Net income was -$12.3M. Revenue was up 76.9% from 2023-09-30 to 2024-09-30. NMTC currently screens at market cap $35.5M.
NMTC currently screens at market cap $35.5M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next NMTC 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the NMTC stock page for the full model, not this heading.
Not investment advice.